APA (7th ed.) Citation

Fahimeh Safaeinejad, Soheyl Bahrami, Heinz Redl, & Hassan Niknejad. (2018). Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Fahimeh Safaeinejad, Soheyl Bahrami, Heinz Redl, and Hassan Niknejad. Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis. Frontiers Media S.A., 2018.

MLA (9th ed.) Citation

Fahimeh Safaeinejad, et al. Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis. Frontiers Media S.A., 2018.